Teicoplanin for Injection – Manufacturer, Exporter & Supplier
What is Teicoplanin for Injection?
Teicoplanin for Injection is a glycopeptide antibiotic used in the treatment of serious and life-threatening infections caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus, and Streptococcus species. It is widely used in hospitals and ICUs as an alternative to vancomycin, offering longer half-life, convenient dosing, and lower nephrotoxicity risk.
Uses of Teicoplanin for Injection
• Treatment of MRSA infections (skin, bone, joint, and lung infections)
• Management of infective endocarditis
• Treatment of septicemia and bacteremia
• Therapy for osteomyelitis and septic arthritis
• Prophylaxis in major surgical procedures at risk of gram-positive infectionsHow Does Teicoplanin for Injection Work?
Teicoplanin inhibits bacterial cell wall synthesis by binding to D-alanyl-D-alanine residues of peptidoglycan precursors. This blocks bacterial cell wall formation, leading to bactericidal activity against gram-positive organisms, including resistant strains.
FAQs on Teicoplanin for Injection
Q1: What is Teicoplanin Injection used for?
It is used for the treatment of serious gram-positive infections, including MRSA, septicemia, and endocarditis.Q2: How is Teicoplanin administered?
It is given by intravenous (IV) injection/infusion or intramuscular (IM) injection under strict medical supervision.Q3: Is Teicoplanin safer than Vancomycin?
Teicoplanin is considered to have lower nephrotoxicity and ototoxicity risks, making it a preferred option in many patients.Q4: Why source Teicoplanin from Farbe Firma Pvt. Ltd.?
Because Farbe Firma ensures GMP-compliant lyophilized production, export dossiers, global regulatory support, and reliable supply.Looking for a reliable Teicoplanin for Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. today for dossier support, registration assistance, and international export supplies.
Product Name
Teicoplanin for Injection
Trade Name
Teicosyl
Available Strength
200 mg, 400 mg
Packing
Lyophilized Vial
Therapeutic Use
Glycopeptide antibiotic – treatment of serious gram-positive bacterial infections including MRSA

